论文部分内容阅读
基因重组人粒细胞集落刺激因子(rhG-CSF),为特异性粒系造血因子,它可促进粒细胞增殖、分化、释放及增强粒细胞功能,加快造血重建,减少化疗骨髓抑制毒性。为观察rhG-CSF对小儿急性淋巴细胞白血病(ALL)化疗所致白细胞减少的疗效,我们总结了近期使用情况,现报道如下。1材料和方法1.1对象1998年2月至1999年10月间小儿ALL
Recombinant human granulocyte-colony stimulating factor (rhG-CSF), a specific myeloid hematopoietic factor, can promote granulocyte proliferation, differentiation, release and enhance granulocyte function, accelerate hematopoietic reconstitution and reduce chemotherapy-induced myelosuppression. To observe the effect of rhG-CSF on chemotherapy-induced leukopenia in children with acute lymphoblastic leukemia (ALL), we summarize the recent use, and are reported below. 1 Materials and Methods 1.1 Object Pediatric ALL from February 1998 to October 1999